Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Titusville › NPI 1053424648
Hospital

North Brevard County Hospital District

North Brevard County Hospital District was paid $8.40M by Medicaid between Jan 2018 and Dec 2024, across 204 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.

33Billing provider infoNORTH BREVARD COUNTY HOSPITAL DISTRICT
TITUSVILLE, FL 32796
33aNPI1053424648assigned 08/16/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.40M
24GClaims451,201
24DCodes billed204
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#59 of 163
Median peer was paid$4.77M
This provider vs. median1.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201834,216$545K
201985,971$1.62M
202083,557$1.52M
202192,419$1.67M
202293,947$1.69M
202343,437$898K
2024incomplete17,654$458K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 21,925 19,472 $1.67M
96361 Intravenous infusion, hydration; each additional hour 9.7% 7,568 4,984 $815K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.7% 12,037 10,372 $647K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.9% 8,127 6,763 $499K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4.1% 3,484 2,888 $345K
36415 Collection of venous blood by venipuncture 4.1% 38,590 22,161 $341K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.6% 1,832 1,567 $300K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.1% 1,903 1,687 $258K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.9% 3,728 870 $243K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.8% 1,821 1,545 $238K
80053 Comprehensive metabolic panel 2.8% 28,510 21,081 $232K
70450 Computed tomography, head or brain; without contrast material 2.5% 3,477 2,812 $214K
192 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.3% 3,173 $191K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.2% 2,384 $183K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.9% 8,314 $164K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.9% 5,555 $159K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.6% 3,959 $133K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 903 $89K
59025 Fetal non-stress test 1.0% 907 $85K
71046 Radiologic examination, chest; 2 views <1% 7,728 $82K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,841 $81K
J3490 Unclassified drugs <1% 8,056 $73K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,180 $68K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 610 $66K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 755 $60K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 4,404 $56K
80048 Basic metabolic panel (calcium, ionized) <1% 7,970 $52K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,892 $46K
H1000 Prenatal care, at-risk assessment <1% 717 $44K
87070 <1% 832 $41K
G0378 Hospital observation service, per hour <1% 2,906 $39K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,220 $34K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 515 $33K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,508 $30K
73610 <1% 704 $30K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 10,290 $28K
81003 <1% 17,314 $28K
82962 <1% 4,502 $25K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 25,947 $23K
72125 Computed tomography, cervical spine; without contrast material <1% 324 $23K
87420 <1% 890 $23K
76801 <1% 864 $22K
71045 Radiologic examination, chest; single view <1% 6,300 $22K
73630 <1% 932 $20K
J7030 Infusion, normal saline solution , 1000 cc <1% 5,540 $20K
A9270 Non-covered item or service <1% 14,372 $20K
85027 <1% 10,691 $20K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,291 $19K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,480 $19K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 242 $19K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,375 $19K
96375 Therapeutic injection; each additional sequential IV push <1% 6,115 $19K
73130 <1% 523 $18K
85610 <1% 7,601 $17K
85730 <1% 6,019 $17K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,610 $16K
81025 <1% 3,894 $13K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 499 $13K
84484 <1% 6,738 $12K
73110 <1% 376 $12K
73030 <1% 401 $10K
J1644 Injection, heparin sodium, per 1000 units <1% 200 $9K
83735 <1% 4,694 $8K
73560 <1% 385 $8K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,261 $8K
96376 <1% 2,659 $8K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 262 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,252 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,337 $7K
77067 Screening mammography, bilateral, including computer-aided detection <1% 394 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,328 $7K
99213 Doctor's office visit, returning patient (routine) <1% 270 $7K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,062 $6K
84443 Thyroid stimulating hormone (TSH) <1% 6,129 $6K
76642 <1% 125 $6K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 48 $6K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 74 $6K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 15 $6K
84702 <1% 1,507 $6K
83690 <1% 4,851 $5K
99214 Doctor's office visit, returning patient (more involved) <1% 134 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,639 $5K
80061 Lipid panel <1% 5,008 $5K
74018 <1% 211 $4K
76830 Ultrasound, transvaginal <1% 124 $4K
94760 <1% 1,095 $4K
97163 <1% 154 $4K
J2704 Injection, propofol, 10 mg <1% 1,323 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 3,629 $3K
84703 <1% 2,701 $3K
82607 <1% 2,057 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 484 $3K
86850 <1% 901 $3K
72100 <1% 195 $3K
86900 <1% 1,413 $3K
82043 <1% 1,407 $3K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,157 $3K
83880 <1% 1,452 $3K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,420 $3K
87186 <1% 2,699 $3K
97161 <1% 65 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,052 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,043 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,545 $2K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 30 $2K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 32 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 101 $2K
97535 Self-care/home management training, each 15 minutes <1% 18 $2K
97597 <1% 20 $2K
86901 <1% 1,403 $2K
12001 <1% 43 $2K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 12 $2K
97162 <1% 47 $2K
87088 <1% 2,395 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,951 $2K
82550 <1% 73 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,348 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 531 $2K
84439 <1% 1,281 $2K
10060 <1% 14 $1K
87040 <1% 990 $1K
85379 <1% 1,226 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 389 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 320 $1K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 20 $896.72
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 295 $888.04
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 947 $812.59
A4340 Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each <1% 82 $796.96
J2550 Injection, promethazine hcl, up to 50 mg <1% 627 $784.60
29125 <1% 68 $761.41
87210 <1% 446 $738.39
99204 Doctor's office visit, new patient (more involved) <1% 21 $734.32
72110 <1% 30 $684.72
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,157 $663.81
77066 Tomosynthesis, mammo <1% 14 $662.89
83605 <1% 172 $644.79
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 622 $623.27
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 211 $622.02
73564 <1% 12 $539.34
76775 <1% 13 $497.35
90715 <1% 225 $493.36
73502 <1% 50 $463.30
99215 Doctor's office visit, returning patient (complex) <1% 13 $454.25
93017 <1% 31 $453.01
12011 <1% 24 $451.81
87075 <1% 348 $414.30
77080 <1% 29 $397.39
83550 <1% 649 $307.59
84550 <1% 192 $261.78
73090 <1% 13 $246.88
80164 <1% 106 $226.16
82140 <1% 127 $212.47
83540 <1% 717 $191.85
85652 <1% 516 $191.72
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 16 $187.91
87081 <1% 90 $177.13
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,055 $164.94
82746 <1% 424 $155.95
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 365 $148.17
86735 <1% 48 $139.23
77063 Screening digital breast tomosynthesis, bilateral <1% 165 $128.74
80055 <1% 28 $125.60
80076 <1% 287 $123.61
3008F <1% 1,011 $104.00
1159F <1% 247 $104.00
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 108 $74.21
82728 <1% 210 $64.55
86762 <1% 47 $53.72
86765 <1% 48 $53.72
86787 <1% 48 $53.72
86140 <1% 277 $52.87
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 114 $43.78
86970 <1% 16 $42.50
82274 <1% 22 $40.08
94644 <1% 16 $35.11
82150 <1% 43 $28.96
86803 <1% 42 $27.84
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 87 $23.53
83970 <1% 81 $22.61
84145 <1% 53 $21.62
J7060 5% dextrose/water (500 ml = 1 unit) <1% 78 $18.34
80177 <1% 28 $17.10
84100 <1% 106 $16.62
84436 <1% 20 $10.05
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 320 $7.38
86038 <1% 17 $6.55
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 0% 28 $0.00
J2060 Injection, lorazepam, 2 mg 0% 753 $0.00
3074F 0% 554 $0.00
3079F 0% 203 $0.00
86592 0% 14 $0.00
1036F 0% 634 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 55 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 0% 18 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 37 $0.00
3075F 0% 12 $0.00
99292 0% 12 $0.00
36600 0% 18 $0.00
3078F 0% 451 $0.00
3725F 0% 519 $0.00
1160F 0% 246 $0.00
29515 0% 14 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 168 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 21 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMIKITARIAN, GEORGE (PRESIDENT/CEO)